Cargando…
Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
This study was to investigate the role of Fas in the development of Cisplatin-resistant ovarian cancer. On the cellular level, Fas expression was significantly reduced in Cisplatin resistant A2780 (A2780/CP) cells compared with A2780 cells. Fas silence with siRNA would promote tumor cell lines proli...
Autores principales: | Yang, Fan, Long, Wang, Xuechuan, Han, Xueqin, Liu, Hongyun, Ma, Yonghui, Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345639/ https://www.ncbi.nlm.nih.gov/pubmed/24755555 http://dx.doi.org/10.5483/BMBRep.2015.48.1.042 |
Ejemplares similares
-
EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells
por: Poursheikhani, Arash, et al.
Publicado: (2020) -
Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells
por: Wu, Wei, et al.
Publicado: (2010) -
Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
por: Cai, J, et al.
Publicado: (2013) -
The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014) -
GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin
por: Nie, Yanting, et al.
Publicado: (2020)